[Greenlight-XPS laser vaporization, the new standard of treatment in men with myasthenia gravis and benign prostatic obstruction]? / La fotovaporización prostática con laser (PVPL) podría constituir una alternativa eficaz y segura a la resección transurethral (RTUP) en pacientes con miastenia gravis.

UNLABELLED: Patients with Benign Prostatic Obstruction (BPO) and Myasthenia Gravis (MG) treated with Transurethral Resection of the prostate (TURP) show a high incidence of urinary incontinence due to unnoticed damage to muscle fibres of the external sphincter. Photoselective laser vaporization could be an alternative treatment based on the hypothesis that using Laser as energy source in the treatment of BPH prevents sphincter damage because the energy is not transmitted outside the fiber tip. METHODS: We report the case of a man diagnosed of MG and symptomatic BPO treated satisfactorily with photoselective laser vaporization (GreenLight-XPS). RESULTS: Patient did not experienced postoperative secondary incontinence. CONCLUSIONS: Laser photoselective vaporization (GreenLight-XPS) could be the standard treatment for men with MG and BPO, whose prostate volume is less than 60 cc who are candidates for surgical treatment. Despite the extremely low incidence of these cases, further investigations are needed to confirm this affirmation.

Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?

Metastatic renal cell carcinoma (mRCC) is a challenging disease. Despite the new targeted therapies, complete remissions occur only in 1%-3% of the cases, and the most effective first-line treatment drugs have reached a ceiling in overall survival (ranging from 9 to 49 mo). Metastasectomy remains to be the only curative option in most patients with mRCC. Prognostic nomograms have been recently published, so we have tools to classify patients in risk groups, allowing us to detect the cases with the higher risk of recurrence after metastasectomy. Although sparse, there is some evidence of effectiveness of neoadjuvant targeted therapy before metastasectomy; but with an increase in surgical complications due to the effects of these new drugs in tissue healing. We have aimed to answer the question: Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma? We have made a search in Pubmed database. As far as we know, evidence is low and it's based in case reports and small series of patients treated with adjuvant drugs after neoadjuvant therapy plus metastasectomy in cases of partial response to initial systemic treatment. Despite the limitations and high risk of bias, promising results and cases with long-term survival with this approach have been described. Two ongoing clinical trials may answer the question that concerns us.

La fotovaporización prostática con láser (PVPL) podría constituir una alternativa eficaz y segura a la resección transuretral (RTUP) en pacientes / Greenlight-XPS laser vaporization, the new standard of treatment in men with myasthenia gravis and benign prostatic obstruction?

OBJETIVOS: Los pacientes con miastenia gravis (MG) diagnosticados de sintomatología del tracto urinario inferior (STUI) secundaria a hiperplasia benigna de próstata (HBP), presentan una elevada incidencia de incontinencia urinaria al ser sometidos a resección transuretral de próstata (RTUp), secundaria a la lesión inadvertida de las fibras musculares del esfínter externo. La fotovaporización prostática con Láser podría ser una alternativa de tratamiento, ya que podría evitar el daño inadvertido del esfínter debido a que la energía no se transmite más allá de la punta de la fibra. MÉTODOS: Presentamos el caso de un varón con antecedente de MG y HBP sintomática tratado de forma satisfactoria mediante fotovaporiazación selectiva con Láser verde (GreenLight-XPS). RESULTADOS: El paciente no presentó incontinencia urinaria tras la cirugía. CONCLUSIONES: La fotovaporización prostática con Láser verde (GreenLight-XPS) podría ser el tratamiento estándar de aquellos varones con MG y HBP candidatos a tratamiento quirúrgico, con volumen prostático menor de 60 cc. A pesar de la baja incidencia de estos pacientes, futuros casos son necesarios para corroborar esta afirmación

Patients with Benign Prostatic Obstruction (BPO) and Myasthenia Gravis (MG) treated with Transurethral Resection of the prostate (TURP) show a high incidence of urinary incontinence due to unnoticed damage to muscle fibres of the external sphincter. Photoselective laser vaporization could be an alternative treatment based on the hypothesis that using Laser as energy source in the treatment of BPH prevents sphincter damage because the energy is not transmitted outside the fiber tip. METHODS: We report the case of a man diagnosed of MG and symptomatic BPO treated satisfactorily with photoselective laser vaporization (GreenLight-XPS). Results Patient did not experienced postoperative secondary incontinence. CONCLUSION: Laser photoselective vaporization (GreenLight-XPS) could be the standard treatment for men with MG and BPO, whose prostate volume is less than 60 cc who are candidates for surgical treatment. Despite the extremely low incidence of these cases, further investigations are needed to confirm this affirmation

[Urethral stricture in women]. / Estenosis uretral en la mujer.

UNLABELLED: To perform a bibliographic review on female urethra stenosis, following the criteria for evidence based medicine. METHODS: We performed a PubMed Search with the following keywords; "female urethral stricture ","women urethral stricture","female urethral reconstruction "and " female urethral stricture treatment ",without time limits, both in English and Spanish languages. RESULTS: Female urethra stenosis is a rare pathology, in which the working diagnosis is essential, as much as detailed physical examination, urodynamic study and radiological tests. We found in the literature a total of 73 cases treated with dilation with or without maintenance self catheterization, 120 cases treated with meatotomy, 65 cases treated by flap urethroplasty (46 with vaginal flap, 17 with vestibular flap and 12 with labia minora graft and 28 with oral mucosa grafts). There are not comparative studies between the various techniques, making it difficult to set up a therapeutic algorithm. CONCLUSIONS: The surgical treatment with flaps/grafts has the highest success rate; whereas less invasive procedures such as urethrotomy/meatotomy/dilations/self-catheterization should be reserved for short female urethra stenosis or women with high comorbidity.

Estenosis uretral en la mujer / Urethral stricture in women

OBJETIVOS: Realización de una revisión bibliográfica sobre la estenosis de uretra femenina (EUF), según los criterios de la Medicina Basada en la Evidencia. MÉTODOS: Búsqueda en Pubmed de los estudios publicados con las siguientes palabras clave: «female urethral stricture», «women urethral stricture», «female urethral reconstruction» y «female urethral stricture treatment», sin límites de tiempo; en inglés y castellano. RESULTADOS: La EUF es una patología poco frecuente, en la que el diagnóstico de sospecha es fundamental; al igual que la exploración física detallada, el estudio urodinámico y las pruebas radiológicas. En total, hemos encontrado en la literatura 73 casos tratados con dilatación con o sin autocateterismos de mantenimiento, 120 casos tratados con meatotomía, 65 casos tratados con uretroplastia con colgajo (46 con colgajo vaginal, 17 con colgajo vestibular y 2 de labio menor) y 53 pacientes tratadas con uretroplastia con injerto (13 con injerto vaginal, 12 con injerto de labio menor y 28 de mucosa oral). No existen estudios comparativos entre las diferentes técnicas, lo que hace difícil establecer un algoritmo terapéutico. CONCLUSIONES: El tratamiento quirúrgico con colgajos/injertos tiene el porcentaje más elevado de éxito; mientras que los procedimientos menos invasivos como la uretrotomía / meatotomía / dilataciones / autocateterismos deberían reservarse para casos con EUF cortas y mujeres con alta comorbilidad

OBJECTIVES: To perform a bibliographic review on female urethra stenosis, following the criteria for evidence based medicine. METHODS: We performed a PubMed Search with the following keywords: «female urethral stricture», «women urethral stricture», «female urethral reconstruction» and «female urethral stricture treatment», without time limits, both in English and Spanish languages. RESULTS: Female urethra stenosis is a rare pathology, in which the working diagnosis is essential, as much as detailed physical examination, urodynamic study and radiological tests. We found in the literature a total of 73 cases treated with dilation with or without maintenance self catheterization, 120 cases treated with meatotomy, 65 cases treated by flap urethroplasty (46 with vaginal flap, 17 with vestibular flap and 12 with labia minora graft and 28 with oral mucosa grafts). There are not comparative studies between the various techniques, making it difficult to set up a therapeutic algorithm. CONCLUSIONS: The surgical treatment with flaps/grafts has the highest success rate; whereas less invasive procedures such as urethrotomy / meatotomy / dilations / self-catheterization should be reserved for short female urethra stenosis or women with high comorbidity

Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen.

OBJECTIVES: To identify risk factors for progression in patients with invasive bladder carcinoma who were pT0/pT1/pTa after cystectomy. METHODS: We analyzed the clinical records of 97 post-cystectomy pT0/pT1/pTa patients for the following variables: hydronephrosis, carcinoma in situ (CIS), lymphovascular invasion, history of non-muscular invasive disease, residual tumor in the specimen and lymphatic invasion (pN). pN+patients were excluded from definitive analysis. The quantitative and qualitative variables were analyzed using standard statistics. The chi-square test was used to analyze associations between categorical variables. Univariate Cox proportional hazard regression analysis (enter method) was performed. The Kaplan-Meier method was used to evaluate survival and the log-rank test to assess differences between groups. Statistical significance was set at p<0.05. The analysis was performed using SPSS version 15.0. RESULTS: The study sample included 97 cases. The specimen was staged at T2 in 97% of patients after transurethral resection (TUR); After cystectomy, the specimen was staged as pT0 (R0) in 44.3% and pT1/Ta (R1) in 55.7%. Median follow-up was 47 months. Lymph node metastasis were detected in 5.2% of patients (pN+rpar; and had a negative impact on survival (p=0.02). Overall survival was 59.8% and cancer-specific survival 76.6%. Univariate analysis showed a relationship between tumor progression and the presence of CIS (p < 0.001), lymphovascular invasion (p=0.049), and hydronephrosis(p < 0.001). In the multivariate analysis, only the presence of CIS in the transurethral resection was associated with reduced cancer-specific survival (HR 100.5; 95% CI, 10.8 to 933.1; pp<0.001). CONCLUSIONS: Although the prognosis of stage pT0/pT1/pTa carcinoma in the cystectomy specimen is excellent, some patients experience progression. The presence of CIS in the transurethral resection was an independent predictor of recurrence in these cases.

Factores de mal pronóstico en pacientes con estadio pT0/pT1/pTa en la pieza de cistectomía radical / Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen

OBJETIVO: Los pacientes con estadio pT0-1-a post-cistectomía tienen una elevada supervivencia, pero un porcentaje de ellos presentará progresión tumoral y muerte por esta causa. Identificación de los factores de riesgo de progresión en pacientes con carcinoma vesical infiltrante que fueron pT0-1-a post-cistectomía. MÉTODOS: Se recogieron 97 pacientes pT0-1 post-cistectomía. Se analizaron las siguientes variables: hidronefrosis, CIS, invasión linfovascular, antecedente de TVNMI, tumor residual en la pieza e invasión linfática (pN). Los pacientes con pN+ fueron excluidos del análisis. Los pacientes con pN+ (5 casos) fueron excluidos del análisis final, que se realizó sobre 92 casos. Las variables cuantitativas y cualitativas se analizaron mediante los estadísticos habituales. La Chi cuadrado se utilizó para evaluar asociaciones entre variables categóricas. Se realizó un análisis univariante y posteriormente se ajustó mediante un modelo de riesgos proporcionales de Cox (método enter). El método de Kaplan-Meier se ha utilizado para evaluar la supervivencia y el test de long-rank para evaluar las diferencias entre los distintos grupos. La significación estadística se consideró cuando existió una p<0,05. Todos los cálculos se han realizado con el programa estadístico SPSS versión 15.0 en castellano. RESULTADOS: 97 casos cumplían los criterios de inclusión. El 97% fueron T2 y el resto T3 en la RTU. El 44,3% fueron pT0 (R0) y el 55,7% pT1-a (R1). La mediana de seguimiento fue de 47 meses. El 5,2% de los pacientes fueron pN+, con un impacto negativo en la supervivencia (p=0,02). La supervivencia global fue del 59,8% y la cáncer-específica del 76,6%. En el análisis univariante se observó una relación entre la progresión tumoral y la presencia de CIS (p<0,001), invasión linfovascular (p=0,049) e hidronefrosis (p<0,001). En el análisis multivariante, solo la presencia de CIS en la RTU se asoció a una menor supervivencia cáncer-específica (HR 100,5; 95% IC 10,8-933,1; p<0,001). CONCLUSIONES: Aunque el pronóstico de los pacientes pT0/pT1/pTa en la pieza de cistectomía es excelente, algunos presentan progresión. La presencia de CIS en la RTU ha demostrado ser un factor predictor de recidiva y progresión independiente de recidiva en estos casos (AU)

OBJECTIVES: To identify risk factors for progression in patients with invasive bladder carcinoma who were pT0/pT1/pTa after cystectomy. METHODS: We analyzed the clinical records of 97 post-cystectomy pT0/pT1/pTa patients for the following variables: hydronephrosis, carcinoma in situ (CIS), lymphovascular invasion, history of non-muscular invasive disease, residual tumor in the specimen and lymphatic invasion (pN). pN+ patients were excluded from definitive analysis. The quantitative and qualitative variables were analyzed using standard statistics. The chi-square test was used to analyze associations between categorical variables. Univariate Cox proportional hazard regression analysis (enter method) was performed. The Kaplan-Meier method was used to evaluate survival and the log-rank test to assess differences between groups. Statistical significance was set at p<0.05. The analysis was performed using SPSS version 15.0. RESULTS: The study sample included 97 cases. The specimen was staged at T2 in 97% of patients after transurethral resection (TUR); After cystectomy, the specimen was staged as pT0 (R0) in 44.3% and pT1/Ta (R1) in 55.7%. Median follow-up was 47 months. Lymph node metastasis were detected in 5.2% of patients (pN+) and had a negative impact on survival (p=0.02). Overall survival was 59.8% and cancer-specific survival 76.6%. Univariate analysis showed a relationship between tumor progression and the presence of CIS (p<0.001), lymphovascular invasion (p=0.049), and hydronephrosis (p<0.001). In the multivariate analysis, only the presence of CIS in the transurtethral resection was associated with reduced cancer-specific survival (HR 100.5; 95% CI, 10.8 to 933.1; p<0.001). CONCLUSIONS: Although the prognosis of stage pT0/pT1/pTa carcinoma in the cystectomy specimen is excellent, some patients experience progression. The presence of CIS in the transurethral resection was an independent predictor of recurrence in these cases (AU)

Urachal adenocarcinoma. Case report and bibliographic review.

OBJECTIVE: Literature review of adenocarcinoma of the urachus in connection with two cases recently diagnosed and treated in our center. METHODS/RESULTS: We report 2 cases of urachus Adenocarcinoma treated in our institution, both underwent extended partial cystectomy including excision of the urachus up to the umbilicus. CONCLUSION: Urachal adenocarcinoma is an exceptional tumor, of poor prognosis, the treatment of which is surgical (partial cystectomy), and the main predictors of disease-free survival are the degree of tumor differentiation and the free margins of the surgical specimen.

Adenocarcinoma de uraco. Presentación de 2 casos y revisión de la literatura / Urachal adenocarcinoma. Case report and bibliographic review

OBJETIVO: Revisión de la literatura del Adenocarcinoma de uraco a propósito de 2 casos diagnosticados y tratados recientemente en nuestro centro. MÉTODOS/RESULTADOS: Describimos 2 casos de adenocarcinoma de uraco tratados en nuestro, ambos sometidos con cistectomía parcial extensa incluyendo resección de el uraco hasta el ombligo. CONCLUSIONES: El adenocarcinoma de uraco es un tumor excepcional, de mal pronóstico, cuyo tratamiento recae fundamentalmente en la cirugía (cistectomía parcial), y donde los principales factores pronóstico de supervivencia libre de enfermedad son el grado de diferenciación tumoral y los márgenes libres de la pieza quirúrgica(AU)

OBJECTIVE: Literature review of adenocarcinoma of the urachus in connection with two cases recently diagnosed and treated in our center. METHODS/RESULTS: We report 2 cases of urachus Adenocarcinoma treated in our institution, both underwent extended partial cystectomy including excision of the urachus up to the umbilicus. CONCLUSION: Urachal adenocarcinoma is an exceptional tumor, of poor prognosis, the treatment of which is surgical (partial cystectomy), and the main predictors of disease-free survival are the degree of tumor differentiation and the free margins of the surgical specimen(Au)

Crioterapia de Rescate en el cáncer de próstata después de Radioterapia / Rescue cryotherapy for prostate cancer after radiotherapy

La Radioterapia es una forma de tratamiento común para el cáncer de próstata localizado. Aproximadamente 1/3 de los pacientes diagnosticados de cáncer de próstata elegirán esta opción para tratar su enfermedad. A pesar de modificaciones en la técnica como la modulación de intensidad, radioterapia conformacional 3-D, braquiterapia asistida por ordenador, un porcentaje significativo de estos pacientes mostrarán un incremento significativo posterior en los valores de PSA. La recidiva local con ausencia de enfermedad a distancia es subsidiaria de tratamiento de rescate. La crioterapia es actualmente ya una opción de intento de tratamiento curativo en pacientes con tumor comprobado por biopsia que muestran una enfermedad localizada, PSA < 10 ngrs/ml. Los avances más recientes tanto tecnológicos como técnicos de la crioterapia de rescate han reducido de forma dramática la morbilidad asociada y hacen que se incremente cada vez más el interés por esta alternativa de tratamiento en esta situación(AU)

Radical Radiotherapy constitutes a useful therapeutic option for localized prostate cancer. Almost one third of prostate cancer patients choose this alternative to treat the disease. Despite modifications in the technique as intensity modulation, 3D conformational radiotherapy or computer-assisted brachytherapy, a significant percentage of these patients will show an increase in PSA values after radiation. Local relapse without distant disease and PSA less than 10 ng/ml are candidates for salvage therapy. Cryotherapy has already become a curative treatment option in this group of patients. Recent technological as well as surgical advances in salvage-cryotherapy have reduced dramatically complications and progressively increase the interest on this alternative(AU)

Sarcoma de Ewing renal primario / Primary renal Ewing`s sarcoma

OBJETIVO: Presentación de dos nuevos casos de sarcoma de Ewing / tumor neuroectodérmico primitivo renal primario, uno de ellos con trombo en cava.MÉTODO: Caracterización de los dos casos clínicos y revisión bibliográfica mediante búsqueda en pubmed.RESULTADO: Presentamos los casos de dos varones diagnosticados de sarcoma de Ewing renal primario, que han sido tratados con nefrectomía y quimioterapia adyuvante; encontrándose en remisión completa hasta la fecha.CONCLUSIÓN: El sarcoma de Ewing / tumor neuroectodérmico primitivo renal primario es una entidad rara que afecta mayoritariamente a adultos jóvenes. La historia natural de estos tumores es la evolución hacia una enfermedad metastásica y la muerte. El tratamiento es multimodal, y combina cirugía y quimioterapia. El papel de la radioterapia no está bien establecido(AU)

OBJECTIVE: To report two new cases of Ewing`s sarcoma/ primitive neuroectodermal tumor of the kidney, one of them with tumor thrombus in cava.METHOD: Characterization of two new cases and literature review by PubMed search.RESULTS: We report the cases of two men diagnosed with primary renal Ewing`s sarcoma, who have been treated with nephrectomy and adjuvant chemotherapy, being in complete remission to date.CONCLUSION: Ewing`s sarcoma / primitive neuroectodermal tumor of the kidney is a rare condition that mainly affects young adults. The natural history of these tumors is the evolution towards metastatic disease and death. Treatment is multimodal, combining surgery and chemotherapy. The role of radiotherapy is not well established

First percutaneous computed tomography-guided radiofrequency ablation of renal tumor in horseshoe kidney.

OBJECTIVE: To report the first case of percutaneous radiofrequency ablation of a tumor in a horseshoe kidney. MATERIALS AND METHODS: A 75-year-old man presented with a 3-cm solid mass on the isthmus of a horseshoe kidney. The tumor was discovered incidentally on a routine computed tomography scan performed during follow-up of a colon carcinoma treated with open hemicolectomy. The patient presented a high anesthetic risk (American Society of Anesthesiologists score of 3) because of a comorbid cardiovascular condition. Biopsy of the mass revealed type I papillary carcinoma. We performed percutaneous radiofrequency ablation using a posterior approach. RESULTS: No complications occurred, and postoperative computed tomography 3 months after the procedure showed no significant contrast enhancement in the treated area. CONCLUSIONS: To our knowledge, this is the first case of a tumor in a horseshoe kidney satisfactorily treated with percutaneous radiofrequency ablation. The technique could represent an alternative to traditional surgery in selected cases.

Villous adenoma in augmentation colocystoplasty asociated to infiltrating urotelial cancer in bladder remanent.

OBJECTIVE: To report a new case of villous adenoma developed in augmentation colocystoplasty. METHODS: Characterization of a new case and review of the literature published to date. RESULTS: We report the case of a 66 year-old man with a villous adenoma and synchronic infiltrating transitional cell carcinoma of the bladder after augmentation colocystoplasty. The latency period until the development of villous adenoma after surgery is long. Treatment consisted of transurethral resection. CONCLUSIONS: Villous adenoma is a benign neoplasm that occurs in the colonic mucosa and shows a high ability to become a malignant colonic cancer. Only two cases of villous adenoma in augmentation colocystoplasty have been reported. We recommend follow up with periodic cystoscopy because of its high malignancy potency.

Adenoma velloso en colocistoplastia de aumento asociado a tumor urotelial infiltrante en el remanente vesical / Villous adenoma in augmentation colocystoplasty asociated to infiltrating urotelial cancer in bladder remanent

OBJETIVO: Presentación de un nuevo caso de adenoma velloso desarrollado en una colocistoplastia de aumento.MÉTODO: Caracterización de un nuevo caso y revisión de la literatura publicada hasta la fecha.RESULTADOS: Presentamos el caso de un varón de 66 años con un adenoma velloso sincrónico con un tumor infiltrante de urotelio vesical y que había sido sometido a una colocistoplastia de aumento por microvejiga tuberculosa. El tiempo de latencia desde la cirugía hasta su aparición fue de 23 años. El tratamiento consistió en su resección transuretral.CONCLUSIONES: El adenoma velloso es un tumor benigno de la mucosa colónica con alto potencial para evolucionar hacia un cáncer de colon infiltrante. Su aparición en colocistoplastias de aumento ha sido previamente descrita en la literatura en dos ocasiones. Recomendamos seguimiento estrecho mediante cistoscopia, dada su capacidad de malignización (AU)

OBJECTIVE: To report a new case of villous adenoma developed in augmentation colocystoplasty.METHODS: Characterization of a new case and review of the literature published to date.RESULTS: We report the case of a 66 year-old man with a villous adenoma and synchronic infiltrating transitional cell carcinoma of the bladder after augmentation colocystoplasty. The latency period until the development of villous adenoma after surgery is long. Treatment consisted of transurethral resection.CONCLUSIONS: Villous adenoma is a benign neoplasm that occurs in the colonic mucosa and shows a high ability to become a malignant colonic cancer. Only two cases of villous adenoma in augmentation colocystoplasty have been reported. We recommend follow up with periodic cystoscopy because of its high malignancy potency (AU)

Priapismo recurrente "stuttering priapism": presentación de un caso y revisión de la literatura / Stuttering priapism: case report and bibliographic review

OBJETIVO: Revisar la forma de presentación, fisiopatología, diagnostico y alternativas terapéuticas del priapismo recurrente mediante la presentación de un nuevo caso.MÉTODOS: Varón de 25 años, estudiado en otro centro por presentar episodios recurrentes de priapismo desde hace aproximadamente 18 meses. Estos episodios se producen a diario, interfiriendo de forma importante con la calidad de vida del paciente.RESULTADOS: Se inicio tratamiento con Bicalutamida 50mg/24h sin mejoría. En la analítica, ecografía dopplerpeneana y arteriografía selectiva de arterias pudendas no se evidenciaron alteraciones. Se pautó Tadalafilo 5mg/24h durante dos meses sin respuesta. Posteriormente se instauró tratamiento con Diazepam 10 mg/24h y Terbutalina 5 mg/24h permitiendo el control de la enfermedad, quedando asintomático en la actualidad.CONCLUSIONES: El priapismo recurrente es una forma poco común de presentación de esta enfermedad, producida por una alteración en los mecanismos de regulación de la erección mediados por la 5PDE y el GMPc.Se han propuesto varios fármacos en su tratamiento con eficacia variable, aunque no existen series suficientemente largas para poder recomendar ninguno como primera opción. El uso de inhibidores de la 5PDE de forma prolongada, ha sido utilizado con éxito por algunos grupos.El conocimiento de estas alternativas, es importante para el tratamiento de esta compleja e infrecuente patología(AU)

OBJECTIVE: To review the presentation, physiopathology, diagnosis and therapeutic alternatives of stuttering priapism with the contribution of a new clinical case.METHODS: A 25 year old man, studied in another center for recurrent episodes of priaprism for about 18 months. These episodes occur daily, significantly interfering with patient´s quality of life.RESULTS: Initially he was treated with Bicalutamide 50mg/24h with no improvement. Blood test, penile Doppler ultrasound and selective arteriography of pudendal arteries showed no abnormalities. Tadalafil 5mg/24h was given for two months without response. Subsequently were treated with Diazepam 10 mg/24h and Terbutaline 5 mg/24h allowing control of the disease, remaining asymptomatic at present.CONCLUSIONS: Stuttering priapism is a rare form of presentation of this disease, caused by an alteration in the regulatory mechanisms of erection mediated by 5PDE and cGMP.Several drugs have been proposed in treatment with variable effectiveness, though there is no series long enough to recommend either as first choice. The use of inhibitors 5PDE so long, has been used successfully by some groups.Knowledge of these alternatives is important for the treatment of this complex and unusual pathology(AU)